Betiatide
Generic Name: betiatide
Brand Names:
Kit For The Preparation Of Technetium Tc99m Mertiatide
DESCRIPTION Kit for the Preparation of Technetium Tc99m Mertiatide is used for the preparation of technetium Tc 99m mertiatide, a diagnostic radiopharmaceutical. It is supplied as a sterile, nonpyrogenic, lyophilized powder. Each vial contains betiatide (N-[N-[N-[(benzoylthio) acetyl]glycyl]glycyl]-glycine).
Overview
DESCRIPTION Kit for the Preparation of Technetium Tc99m Mertiatide is used for the preparation of technetium Tc 99m mertiatide, a diagnostic radiopharmaceutical. It is supplied as a sterile, nonpyrogenic, lyophilized powder. Each vial contains betiatide (N-[N-[N-[(benzoylthio) acetyl]glycyl]glycyl]-glycine).
Uses
INDICATIONS AND USAGE Technetium Tc 99m mertiatide is a renal imaging agent for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi in adults and pediatric patients. (See Pediatric Use .) It is a diagnostic aid in providing renal function, split function, renal angiograms, and renogram curves for whole kidney and renal cortex.
Dosage
DOSAGE AND ADMINISTRATION The suggested dose range employed in the average adult patient (70kg) for renal function and imaging studies is 185 MBq (5 mCi) to 370 MBq (10 mCi). In pediatric patients the recommended dose range is 2.6 MBq/kg (70 μCi/kg) to 5.2 MBq/kg (140 μCi/kg) with a minimum dose of 37 MBq (1 mCi). The patient dose should be measured by a suitable radioactivity calibration system immediately prior to administration. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration. Aseptic procedures and a shielded syringe should be employed in withdrawing doses for administration to patients. The user should wear waterproof gloves during the administration procedure.
Side Effects
ADVERSE REACTIONS The following adverse reactions have been reported: nausea, vomiting, wheezing, dyspnea, itching, rash, tachycardia, hypertension, shaking chills, fever, and seizure.
Warnings
WARNINGS None known. CONTRAINDICATIONS None known.
Pregnancy
Pregnancy Pregnancy Category C Animal reproduction studies have not been conducted with technetium Tc 99m mertiatide. It is also not known whether this drug can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Technetium Tc 99m mertiatide should be given to a pregnant woman only if clearly needed.
Storage
STORAGE Kit for the Preparation of Technetium Tc 99m Mertiatide should be stored at controlled room temperature 20°C to 25°C (68-77°F) and protected from light until use. The reconstituted vial should be stored at room temperature (15°C to 30°C) and must be used within six hours of preparation.
Frequently Asked Questions
What is Betiatide used for?▼
INDICATIONS AND USAGE Technetium Tc 99m mertiatide is a renal imaging agent for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi in adults and pediatric patients. (See Pediatric Use .) It is a diagnostic aid in providing renal function, split function, renal angiograms, and renogram curves for whole kidney and renal cortex.
What are the side effects of Betiatide?▼
ADVERSE REACTIONS The following adverse reactions have been reported: nausea, vomiting, wheezing, dyspnea, itching, rash, tachycardia, hypertension, shaking chills, fever, and seizure.
Can I take Betiatide during pregnancy?▼
Pregnancy Pregnancy Category C Animal reproduction studies have not been conducted with technetium Tc 99m mertiatide. It is also not known whether this drug can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Technetium Tc 99m mertiatide should be given to a pregnant woman only if clearly needed.
What are the important warnings for Betiatide?▼
WARNINGS None known. CONTRAINDICATIONS None known.
Related Medications
Aletris Farinosa Root, Graphite, Chamaelirium Luteum Root, Pilocarpus Jaborandii Leaf, Lachesis Muta Venom, Anemone Pratensis Flowering Top, Sanguinaria Canadensis Root, And Lamium Album Flowering Top
aletris farinosa root, graphite, chamaelirium luteum root, pilocarpus jaborandii leaf, lachesis muta venom, anemone pratensis flowering top, sanguinaria canadensis root, and lamium album flowering top
For relief of minor menopausal symptoms. Application of this homeopathic remedy for the designated usage is exclusively based on homeopathic experience. With severe forms of this disease, a clinically proven therapy is indicated.
Chelidonium Majus, Echinacea (angustifolia), Juniperus Communis, Rhamnus Purshiana, Stigmata Maidis, Taraxacum Officinale, Uva-ursi, Sarsaparilla (smilax Regelii), Galium Aparine, Gallbladder (bovine), Hepar (bovine), Kidney (bovine), Rumex Crispus, Thymus (ovine), Urinary Bladder (suis), Lymph Node (suis)
chelidonium majus, echinacea (angustifolia), juniperus communis, rhamnus purshiana, stigmata maidis, taraxacum officinale, uva-ursi, sarsaparilla (smilax regelii), galium aparine, gallbladder (bovine), hepar (bovine), kidney (bovine), rumex crispus, thymus (ovine), urinary bladder (suis), lymph node (suis)
Non-Standardized Food Allergenic Extract [EPC]
PURPOSE: Chelidonium Majus – Assists in Removal of Toxins, Aches and Pains,† Echinacea – Headache, Immune Support, Weakness, Aches and Pains,† Galium Aparine – Assists in Removal of Toxins,† Gallbladder – Support of Gallbladder,† Hepar (Liver) – Support of Liver,† Juniperus Communis - Antioxidant,† Kidney – Support of Kidneys,† Lymph Node – Support and Drainage of Lymphatic System,† Rhamnus Purshiana – Constipation, Assists in Removal of Toxins,† Rumex Crispus – Antioxidant, Assists in Removal o
Dapagliflozin (dapagliflozin 30% W/w Solution In Isopropyl Alcohol)
dapagliflozin (dapagliflozin 30% w/w solution in isopropyl alcohol)
Dosage form: LIQUID. Active ingredients: DAPAGLIFLOZIN (10 g/10g). Category: BULK INGREDIENT.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.